EFFECTS OF BENZTROPINE ON BEHAVIORAL AND TOXIC EFFECTS OF COCAINE - COMPARISON WITH ATROPINE AND THE SELECTIVE DOPAMINE UPTAKE INHIBITOR HENYLMETHOXY)ETHYL]-4-(3-PHENYL-PROPYL)-PIPERAZINE
Jb. Acri et al., EFFECTS OF BENZTROPINE ON BEHAVIORAL AND TOXIC EFFECTS OF COCAINE - COMPARISON WITH ATROPINE AND THE SELECTIVE DOPAMINE UPTAKE INHIBITOR HENYLMETHOXY)ETHYL]-4-(3-PHENYL-PROPYL)-PIPERAZINE, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 198-206
Behavioral effects of cocaine that are relevant to its abuse have been
associated with pharmacological actions at the dopamine uptake carrie
r. Benztropine (Cogentin) is an antiparkinson agent that has limited a
buse despite its ability to block dopamine uptake, and has been sugges
ted as a candidate for the treatment of cocaine dependence. Preclinica
l studies were conducted to assess the behavioral and toxic effects of
benztropine alone and in conjunction with cocaine, Because of the mix
ed pharmacology of benztropine which includes antimuscarinic as well a
s dopaminergic actions, results obtained from parallel experiments wit
h atropine and the selective dopamine uptake inhibitor, GBR 12935 nylm
ethoxy)ethyl]-4-(3-phenyl-propyl)-piperazine}, were performed, All of
the drugs stimulated locomotor activity of mice, but atropine and benz
tropine had much lower efficacy. Nonstimulatory doses of GBR 12935 enh
anced the locomotor stimulant effects of cocaine, whereas benztropine
and atropine did not share this effect. GBR 12935, benztropine and coc
aine increased fixed-interval responding, whereas atropine decreased f
ixed-interval response rates in rats. Only GBR 12935 and cocaine incre
ased responding during timeout periods. GBR 12935, but not benztropine
or atropine, fully reproduced the discriminative stimulus effects of
cocaine (10 mg/kg). GBR 12935 and atropine augmented the discriminativ
e stimulus effects of lower cocaine doses in rats. Only GBR 12935 and
cocaine had convulsant effects and only GBR 12935 significantly enhanc
ed the convulsant effects of cocaine in mice. These results document a
behavioral and toxicity profile for benztropine distinct from that of
classical dopamine uptake blockers. The data underscore further the p
otential of benztropine as a candidate for clinical evaluation in the
treatment of cocaine dependence.